Michaela Kadlecova
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Empagliflozin in combination with trandolapril but not with triple therapy improves glucose and lipid metabolism in non-diabetic hypertensive model.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 08, 2025
Corrigendum for: Sex Differences in Blood Pressure, Free Radicals and Plasma Cholesterol Fractions in Ren-2 Transgenic Rats of Various Ages.
Journal: Physiological research
Published: November 28, 2023
Hepatoprotective and cardioprotective effects of empagliflozin in spontaneously hypertensive rats fed a high-fat diet.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 31, 2023
Sex differences in blood pressure, free radicals and plasma cholesterol fractions in Ren-2 transgenic rats of various ages.
Journal: Physiological research
Published: May 09, 2023
Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease.
Journal: Biomedicines
Published: September 09, 2022
Antihypertensive and metabolic effects of empagliflozin in Ren-2 transgenic rats, an experimental non-diabetic model of hypertension.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 20, 2021
Sex differences in blood pressure of aged Ren-2 transgenic rats.
Journal: Physiological research
Published: March 22, 2020
Distinct effects of bosentan on NO-dependent vasodilation and calcium influx in heterozygous Ren-2 transgenic rats on high-salt diet.
Journal: Physiological research
Published: August 20, 2019
Renoprotection Provided by Additional Diuretic Treatment in Partially Nephrectomized Ren-2 Transgenic Rats Subjected to the Combined RAS and ETA Blockade.
Journal: Frontiers in physiology
Published: May 24, 2019
Role of angiotensin II in chronic blood pressure control of heterozygous Ren-2 transgenic rats: Peripheral vasoconstriction versus central sympathoexcitation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 11, 2019
Renoprotective effects of ET(A) receptor antagonists therapy in experimental non-diabetic chronic kidney disease: Is there still hope for the future?
Journal: Physiological research
Published: June 28, 2018
Last Updated: 09/26/2026